Multiple sclerosis drug
Merz and A&O overturn PI decision in Fampyra case in second instance at the UPC
After a defeat at first instance, Merz has now succeeded in obtaining a PI in its fight to protect Fampyra at the Court of Appeal. Viatris is now bann
...
29 April 2026 by Konstanze Richter